Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiocca

Showing results (571-580 of 728) with videos related to

Pageof 73
Sort By:
Molecular Therapy Oncolytics|January 1, 2020
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal SurvivalPaola Sette, Nduka Amankulor, Aofei Li, et al.
Cancer Research|December 4, 2015
TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune ResponseJianfeng Han, Xilin Chen, Jianhong Chu, et al.
Oncotarget|March 5, 2015
MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastomaNadiya M Teplyuk, Erik J Uhlmann, Andus Hon-Kit Wong, et al.
Scientific Reports|March 22, 2020
Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responsesQuazim A Alayo, Hirotaka Ito, Carmela Passaro, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2026
NSD2 upregulation is driven by high-risk HPV E6/E7 and disrupts epithelial differentiation in HPV-associated head and neck cancerLavinia Ghiani, Simona Citro, Alessandro Medda, et al.
Stem Cell Reports|May 23, 2017
MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular TransferJakub Godlewski, Ruben Ferrer-Luna, Arun K Rooj, et al.
Radiology|December 4, 2002
In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experienceJames D Rabinov, Patricia Lani Lee, Frederick G Barker, et al.
Gene Therapy|December 21, 2012
Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSVP-Y Wang, M A Currier, L Hansford, et al.
International Journal of Molecular Sciences|March 18, 2020
FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular VesiclesFranz L Ricklefs, Cecile L Maire, Jakob Matschke, et al.
Nature Biomedical Engineering|October 10, 2022
Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood-brain barrier in rodents and primatesYizheng Yao, Jun Wang, Yi Liu, et al.
Pageof 73

Showing results (571-580 of 728) with videos related to

Sort By:
Pageof 73
Molecular Therapy Oncolytics|January 1, 2020
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal SurvivalPaola Sette, Nduka Amankulor, Aofei Li, et al.
Cancer Research|December 4, 2015
TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune ResponseJianfeng Han, Xilin Chen, Jianhong Chu, et al.
Oncotarget|March 5, 2015
MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastomaNadiya M Teplyuk, Erik J Uhlmann, Andus Hon-Kit Wong, et al.
Scientific Reports|March 22, 2020
Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responsesQuazim A Alayo, Hirotaka Ito, Carmela Passaro, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2026
NSD2 upregulation is driven by high-risk HPV E6/E7 and disrupts epithelial differentiation in HPV-associated head and neck cancerLavinia Ghiani, Simona Citro, Alessandro Medda, et al.
Stem Cell Reports|May 23, 2017
MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular TransferJakub Godlewski, Ruben Ferrer-Luna, Arun K Rooj, et al.
Radiology|December 4, 2002
In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experienceJames D Rabinov, Patricia Lani Lee, Frederick G Barker, et al.
Gene Therapy|December 21, 2012
Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSVP-Y Wang, M A Currier, L Hansford, et al.
International Journal of Molecular Sciences|March 18, 2020
FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular VesiclesFranz L Ricklefs, Cecile L Maire, Jakob Matschke, et al.
Nature Biomedical Engineering|October 10, 2022
Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood-brain barrier in rodents and primatesYizheng Yao, Jun Wang, Yi Liu, et al.
Pageof 73